Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
45 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
ALK-Abello A/S - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'ALK-Abello A/S - Product Pipeline Review - 2014', provides an overview of the ALK-Abello A/S's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ALK-Abello A/S's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of ALK-Abello A/S including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of ALK-Abello A/S's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the ALK-Abello A/S's pipeline products Reasons to buy - Evaluate ALK-Abello A/S's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of ALK-Abello A/S in its therapy areas of focus - Identify new drug targets and therapeutic classes in the ALK-Abello A/S's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of ALK-Abello A/S and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of ALK-Abello A/S - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of ALK-Abello A/S and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 ALK-Abello A/S Snapshot 5 ALK-Abello A/S Overview 5 Key Information 5 Key Facts 5 ALK-Abello A/S - Research and Development Overview 6 Key Therapeutic Areas 6 ALK-Abello A/S - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 ALK-Abello A/S - Pipeline Products Glance 11 ALK-Abello A/S - Late Stage Pipeline Products 11 Pre-Registration Products/Combination Treatment Modalities 11 Phase III Products/Combination Treatment Modalities 12 ALK-Abello A/S - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 ALK-Abello A/S - Early Stage Pipeline Products 14 Discovery Products/Combination Treatment Modalities 14 ALK-Abello A/S - Drug Profiles 15 allergenic pollen extract of timothy 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 short ragweed pollen allergen OD 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 MK-7243 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 MK-8237 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 AVANZ Olive Immunotherapy for Allergic Rhinitis 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Avanz Phleum Pratense 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 ALK Birch Pollen Vaccine 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Avanz Cupressus Immunotherapy for Allergic Rhino-Conjunctivitis 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Avanz Salsola Immunotherapy for Allergic Rhino-Conjunctivitis 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 ALK Next Generation Vaccine 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 ALK Recombinant Cat Vaccine 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 ALK-Abello A/S - Pipeline Analysis 29 ALK-Abello A/S - Pipeline Products by Route of Administration 29 ALK-Abello A/S - Pipeline Products by Molecule Type 30 ALK-Abello A/S - Recent Pipeline Updates 31 ALK-Abello A/S - Dormant Projects 37 ALK-Abello A/S - Company Statement 38 ALK-Abello A/S - Locations And Subsidiaries 41 Head Office 41 Other Locations & Subsidiaries 41 ALK-Abello A/S - Key Manufacturing Facilities 43 Appendix 44 Methodology 44 Coverage 44 Secondary Research 44 Primary Research 44 Expert Panel Validation 44 Contact Us 45 Disclaimer 45
List of Tables ALK-Abello A/S, Key Information 5 ALK-Abello A/S, Key Facts 5 ALK-Abello A/S - Pipeline by Indication, 2014 8 ALK-Abello A/S - Pipeline by Stage of Development, 2014 9 ALK-Abello A/S - Monotherapy Products in Pipeline, 2014 10 ALK-Abello A/S - Pre-Registration, 2014 11 ALK-Abello A/S - Phase III, 2014 12 ALK-Abello A/S - Phase II, 2014 13 ALK-Abello A/S - Discovery, 2014 14 ALK-Abello A/S - Pipeline by Route of Administration, 2014 29 ALK-Abello A/S - Pipeline by Molecule Type, 2014 30 ALK-Abello A/S - Recent Pipeline Updates, 2014 31 ALK-Abello A/S - Dormant Developmental Projects,2014 37 ALK-Abello A/S, Other Locations 41 ALK-Abello A/S, Subsidiaries 41 ALK-Abello A/S, Key Manufacturing Facilities 43
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.